A comprehensive intervention associated with reduced surgical site infections among pediatric cardiovascular surgery patients, including those with delayed closure

Journal of the Pediatric Infectious Diseases Society

Volumn 1, Issue 1, 2012, Pages 35-43

  Adler, Amanda L ^a   Martin, Emily T ^a   Cohen, Gordon ^a,b   Jeffries, Howard ^a,b   Gilbert, Michael ^a,b   Smith, Julie ^a   Zerr, Danielle M ^a,b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ANTIBIOTIC AGENT; CEFAZOLIN; CHLORAPREP; CHLORHEXIDINE GLUCONATE; CLINDAMYCIN; POVIDONE IODINE; PSEUDOMONIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CARDIOVASCULAR SURGERY; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; INCISION; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

EID: 84905585739     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis008     Document Type: Article

References (25)

1. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783-805.
2. Wong ES. Surgical site infection. In: Mayhall CJ, ed. Hospital epidemiology and infection control. 2nd ed. Philadelphia: Lippincott, Williams, & Wilkins, 1999:189-210.
3. Allpress AL, Rosenthal GL, Goodrich KM, Lupinetti FM, Zerr DM. Risk factors for surgical site infections after pediatric cardiovascular surgery. Pediatr Infect Dis J 2004; 23:231-4.
4. Nateghian A, Taylor G, Robinson JL. Risk factors for surgical site infections following open-heart surgery in a Canadian pediatric population. Am J Infect Control 2004; 32:397-401.
5. Mehta PA, Cunningham CK, Colella CB, Alferis G, Weiner LB. Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J 2000; 19:1000-4.
6. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. Am J Infect Control 2010; 38:706-10.
7. Long CB, Shah SS, Lautenbach E, et al. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J 2005; 24:315-9.
8. Johnson JN, Jaggers J, Li S, et al. Center variation and outcomes associated with delayed sternal closure after stage 1 palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2010; 139:1205-10.
9. Costello JM, Graham DA, Morrow DF, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg 2010; 89:1833-41; discussion 41-2.
10. Holzmann-Pazgal G, Hopkins-Broyles D, Recktenwald A, et al. Case-control study of pediatric cardiothoracic surgical site infections. Infect Control Hosp Epidemiol 2008; 29:76-9.
11. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-78; quiz 79-80.
12. Institute for Healthcare Improvement. Pediatric surgical site infection guideline. Available at: http://www.ihi.org/IHI/Programs/Campaign/SSI.htm. Accessed 14 March 2010.
13. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008 Oct;29 Suppl 1:S51-61.
14. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002; 123:110-8.
15. Alexi-Meskishvili V, Weng Y, Uhlemann F, Lange PE, Hetzer R. Prolonged open sternotomy after pediatric open heart operation: experience with 113 patients. Ann Thorac Surg 1995; 59:379-83.
16. Levy I, Ovadia B, Erez E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect 2003; 53:111-6.
17. Das S, Rubio A, Simsic JM, et al. Bloodstream infections increased after delayed sternal closure: cause or coincidence. Ann Thorac Surg 2011; 91:793-7.
18. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005; 140:174-82.
19. Forbes SS, Stephen WJ, Harper WL, et al. Implementation of evidence-based practices for surgical site infection prophylaxis: results of a preand postintervention study. J Am Coll Surg 2008; 207:336-41.
20. Fellinger EK, Leavitt BJ, Hebert JC. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery. Ann Thorac Surg 2002; 74:1187-90.
21. Hatzopoulos FK, Stile-Calligaro IL, Rodvold KA, Sullivan-Bolyai J, Del Nido P, Levitsky S. Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery. Pediatr Infect Dis J 1993; 12:300-4.
22. Lonsky V, Dominik J, Mand'ak J, et al. Changes of the serum antibiotic levels during open heart surgery (ceftazidim, ciprofloxacin, clindamycin). Acta Medica (Hradec Kralove) 2000; 43:23-7.
23. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172-9.
24. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346:1871-7.
25. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362:9-17.